FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/19/2020.
This two-page document provides answers to frequently asked questions about providing methadone and buprenorphine for the treatment of opioid use disorder during the COVID-19 (coronavirus) epidemic. Topics include the use of telehealth for new and existing patients, and dispensing medication based on telehealth.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
More News: Coronavirus | COVID-19 | Emergency Medicine | Epidemics | Epidemiology | International Medicine & Public Health | Men | Methadone | Substance Abuse | Substance Abuse Disorders